419 related articles for article (PubMed ID: 33198323)
21. The application of proteomics in different aspects of hepatocellular carcinoma research.
Xing X; Liang D; Huang Y; Zeng Y; Han X; Liu X; Liu J
J Proteomics; 2016 Aug; 145():70-80. PubMed ID: 27072111
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
Macha MA; Seshacharyulu P; Krishn SR; Pai P; Rachagani S; Jain M; Batra SK
Curr Pharm Des; 2014; 20(33):5287-97. PubMed ID: 24479799
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what's better?
Milione M
Endocrine; 2018 Jan; 59(1):1-3. PubMed ID: 28417314
[No Abstract] [Full Text] [Related]
24. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
Chiou SH; Lee KT
Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
[TBL] [Abstract][Full Text] [Related]
25. Glycopattern Alteration of Glycoproteins in Gastrointestinal Cancer Cell Lines and Their Cell-Derived Exosomes.
Zhang J; Qin Y; Jiang Q; Li F; Jing X; Cao L; Cai S; Wu F; Li Q; Lian J; Song Y; Huang C
J Proteome Res; 2022 Aug; 21(8):1876-1893. PubMed ID: 35786973
[TBL] [Abstract][Full Text] [Related]
26. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
[TBL] [Abstract][Full Text] [Related]
27. Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation.
Ji Y; Wei S; Hou J; Zhang C; Xue P; Wang J; Chen X; Guo X; Yang F
Oncotarget; 2017 Feb; 8(8):13413-13427. PubMed ID: 28077793
[TBL] [Abstract][Full Text] [Related]
28. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
[TBL] [Abstract][Full Text] [Related]
29. Network analysis and proteomic identification of vimentin as a key regulator associated with invasion and metastasis in human hepatocellular carcinoma cells.
Pan TL; Wang PW; Huang CC; Yeh CT; Hu TH; Yu JS
J Proteomics; 2012 Aug; 75(15):4676-92. PubMed ID: 22387118
[TBL] [Abstract][Full Text] [Related]
30. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
Peng XQ; Wang F; Geng X; Zhang WM
Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers for personalized medicine in GI cancers.
Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
[TBL] [Abstract][Full Text] [Related]
32. Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery.
Niu D; Feng H; Chen WN
J Proteomics; 2010 May; 73(7):1283-90. PubMed ID: 20188222
[TBL] [Abstract][Full Text] [Related]
33. Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers.
Li Y; Sui S; Goel A
Semin Cancer Biol; 2024 Feb; 99():5-23. PubMed ID: 38341121
[TBL] [Abstract][Full Text] [Related]
34. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
Ferreira JA; Magalhães A; Gomes J; Peixoto A; Gaiteiro C; Fernandes E; Santos LL; Reis CA
Cancer Lett; 2017 Feb; 387():32-45. PubMed ID: 26828132
[TBL] [Abstract][Full Text] [Related]
35. Circular RNAs as diagnostic biomarker in pancreatic cancer.
Fathizadeh H; Hallajzadeh J; Asemi Z
Pathol Res Pract; 2020 Sep; 216(9):153075. PubMed ID: 32825948
[TBL] [Abstract][Full Text] [Related]
36. Integrative molecular analysis of colorectal cancer and gastric cancer: What have we learnt?
Athauda A; Segelov E; Ali Z; Chau I
Cancer Treat Rev; 2019 Feb; 73():31-40. PubMed ID: 30597479
[TBL] [Abstract][Full Text] [Related]
37. Proteomics for the early detection and treatment of hepatocellular carcinoma.
Feng JT; Shang S; Beretta L
Oncogene; 2006 Jun; 25(27):3810-7. PubMed ID: 16799622
[TBL] [Abstract][Full Text] [Related]
38. Use of proteomic patterns to screen for gastrointestinal malignancies.
Feldman AL; Espina V; Petricoin EF; Liotta LA; Rosenblatt KP
Surgery; 2004 Mar; 135(3):243-7. PubMed ID: 14976472
[No Abstract] [Full Text] [Related]
39. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
Lee PY; Chin SF; Low TY; Jamal R
J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
[TBL] [Abstract][Full Text] [Related]
40. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
